Trials / Completed
CompletedNCT05870657
Adherence and Persistence to Inclisiran Among Early Users in Germany
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,109 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present study was a descriptive, non-interventional, retrospective cohort study aimed at evaluating early data on adherence, persistence, and treatment patterns among patients receiving inclisiran and other lipid-lowering therapies (LLT) in a real-world setting in Germany. Analysis was carried out using the IQVIA™ LRx database.
Conditions
Timeline
- Start date
- 2022-02-16
- Primary completion
- 2022-05-12
- Completion
- 2022-05-12
- First posted
- 2023-05-23
- Last updated
- 2023-05-23
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05870657. Inclusion in this directory is not an endorsement.